Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

500 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

NCT01844765

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Lucile Salter Packard Children's Hospital at Stanford Palo Alto, California, United States
  • Nemours Childrens Hospital Orlando, Florida, United States
  • St. Mary's Hospital West Palm Beach, Florida, United States
View all 36 locations
View Trial Details
Completed

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

NCT04192916

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Mount Sinai New York New York, United States
  • Princess Margaret Cancer Centre Toronto Toronto, Canada
  • Centre Hospitalier Universitaire de Brest Brest, France
  • RWTH Aachen University Aachen, Germany
View all 18 locations
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT02029950

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Myelomonocytic Leukemia-2, +10 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details

Related conditions